61. 自己免疫性溶血性貧血 Autoimmune hemolytic anemia Clinical trials / Disease details

臨床試験数 : 146 / 薬物数 : 131 - (DrugBank : 59) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 158

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2022-001773-31-ES (EUCTR)	14/02/2023	11/10/2022	A study of efficacy and safety of ianalumabin previously treated patients with warm autoimmune haemo ...	A phase 3, randomized, double-blind, study to assess efficacy and safety of ianalumab(VAY736) versus ...	warm autoimmune haemolytic anaemia (wAIHA) MedDRA version: 25.0;Level: LLT;Classification code 10047 ...	Product Name: Ianalumab Product Code: VAY736 INN or Proposed INN: Ianalumab	Novartis Farmacéutica, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	Argentina;Singapore;Hungary;United States;Japan;United Kingdom;Malaysia;Thailand;Spain;India;China;T ...
2	NCT05648968 (ClinicalTrials.gov)	December 30, 2022	23/11/2022	A Study of Efficacy and Safety of Ianalumabin Previously Treated Patients With Warm Autoimmune Hemol ...	A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab(VAY736) Versus ...	Warm Autoimmune Hemolytic Anemia (wAIHA)	Biological: Ianalumab;Drug: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	90	Phase 3	Singapore

First Previous1Next Last